Skip to main content
. 2021 Jan 30;49(3):491–500. doi: 10.1007/s15010-020-01572-8

Table 2.

Echocardiographic parameters

Number (%) or median (IQR) All (n = 32) With myocardial injury (n = 18) Without myocardial injury (n = 14) p-value
Left ventricular dimensions
 LVEDD, mm 48 (45–51) 48 (46–52) 47 (43–49) 0.208
 LVESD, mm 38 (33–42) 40 (34–44) 35 (32–40) 0.165
 LV mass, g 143 (125–181) 156 (135–179) 135 (118–197) 0.287
 MV, ml 137.6 (121.9–172.6) 148.6 (133.8–171.9) 128.6 (111.9–187.1) 0.196
 3D-LVEDV, ml 131 (113–156) 131 (113–147) 131 (117–159) 0.805
 3D-LVESV, ml 56.0 (48.3–72.0) 56 (50–76) 56 (41–64) 0.518
 3D-LAV, ml 66 (48–93) 77 (48–104) 57 (49–69) 0.119
Systolic left ventricular function
 MCF, ratio 0.50 (0.43–0.57) 0.47 (0.39–0.55) 0.55 (0.49–0.64) 0.016
 3D-LVEF, % 55 (50–62) 52 (46–61) 59 (53–64) 0.074
 Forward LV SV, ml 72 (58–90) 67 (57–85) 78 (62–93) 0.362
 LV-GLS, % −15.1 (−11.7 to −18.8) −13.9 (−9.3 to −16.5) −17.7 (−14.8 to −19.8) 0.005
Diastolic left ventricular function
 E/A, ratio 0.9 (0.7–1.1) 0.7 (0.7–0.9) 1.1 (0.9–1.2) 0.004
 Mitral E velocity, cm/s 74.7 (57.1–85.6) 60.0 (50.1–75.9) 80.9 (74.1–87.2) 0.002
 Average E/e′, ratio 7.7 (6.3–9.7) 7.6 (5.9–8.9) 8.2 (6.5–10.5) 0.471
 Septal e′ velocity, cm/s 7.9 (6.5–9.8) 6.6 (5.4–8.6) 9.6 (7.9–11.1) 0.005
 Lateral e′ velocity, cm/s 10.6 (8.7–12.8) 9.3 (8.1–10.8) 12.7 (10.1–14.9) 0.017
 TR velocity, cm/s 195.0 (139.5–217.0) 199.4 (123.5–214.5) 162.0 (139.5–219.5) 0.790
 3D-LAV index, ml/m2 36.0 (24.8–47.4) 44.4 (31.6–52.1) 29.6 (23.5–37.6) 0.134
Right ventricular dimensions
 3D-RVEDV, ml 108.0 (89.0–126.5) 112.5 (95.4–127.0) 99.2 (82.5–123.0) 0.305
 3D-RVESV, ml 58.2 (46.3–73.5) 67.5 (57.5–77.7) 51.5 (43.2–57.5) 0.019
 RV mid, mm 34.5 (31.7–39.0) 34.8 (31.9–39.2) 34.3 (30.5–39.1) 0.704
 RV length, mm 75.6 (72.1–80.5) 76.0 (72.4–81.0) 75.6 (71.4–80.9) 0.704
 RA volume, ml 44.6 (34.5–62.4) 46.9 (40.7–59.7) 42.9 (33.0–63.7) 0.427
Right ventricular function
 TAPSE, mm 23.5 (19.8–27.0) 26.0 (20.5–28) 22.0 (18.8–25.5) 0.074
 FAC, % 40 (35–45) 37 (29–43) 43 (40–48) 0.014
 3D-RVEF, % 44 (39–49) 40 (34–44) 49 (46–53) 0.001
 Global RV SV, ml 45.4 (39.3–54.0) 43.1 (31.3–53.7) 49.4 (42.7–55.1) 0.154
 RV-FWS, % -24.0 (-17.2- -29.0) -18.5 (-13.6- -24.6) -28.3 (-24.2- -32.2) 0.003
 TR peak, mmHg 16.5 (9.3–21.5) 17.5 (9.5–26.0) 13.5 (8.5–21.0) 0.487
 Echo-sPAP, mmHg 1.19 (0.76–1.85) 1.20 (0.78–1.61) 1.05 (0.76–2.42) 0.935
 RV S′ max, mm/s 16.0 (12.5–18.9) 15.2 (11.9–19.8) 16.0 (12.6–18.2) 0.739
 VCI width, mm 15 (13–19) 16 (13–19) 15 (14–19) 0.873

3D, three-dimensional; LVEDD, left ventricular diastolic diameter; LVESD, left ventricular systolic diameter; LV, left ventricle; MV, myocardial volume; LVEDV/RVEDV, left/right ventricular end-diastolic volume; LVESV/RVESV, left /right ventricular end-systolic volume; LA, left atrial volume; MCF, myocardial contraction fraction; LVEF/RVEF, left /right ventricular ejection fraction; SV, stroke volume; GLS, global longitudinal strain; E/A, ratio of mitral E-wave to A-wave; RV, right ventricle; RA, right atrial; TAPSE, tricuspid annular plane systolic excursion; FAC, fractional area change; RV-FWS, right ventricular free wall strain; TR, tricuspid regurgitation; sPAP, systolic pulmonary artery pressure; S′ max, maximum systolic excursion velocity; VCI, vena cava inferior